Uveitis Treatment Market is likely to expand at a stable CAGR of 6.5% During 2016-2024

Digital Daily NewsRead the rest

BlueWater Angels among state’s most enviable investors

Crain’s Detroit BusinessRead the rest

Allergan prepares to expand Waco facility after delays

Waco Tribune-HeraldRead the rest

Tech Coast Angels Invested $14.1 Million into 55 Companies and Completed Six Exits in 2016

For PR Web, click here

During its 20th Year, Angel Network also Launched Angel Syndication Network to Share Deals with over 20 Other Angel Groups 

IRVINE, Calif. – April 25, 2017 – Tech Coast Angels (TCA) invested $14.1 million in a total of 55 companies in a diverse mix of industries in 2016.… Read the rest

Retrosense Therapeutics: Looking beyond Traverse City’s tourism: Northern Michigan angel fund aims to broaden economic base, create year-round jobs

Crain’s Detroit BusinessRead the rest

Retrosense Therapeutics: Life sciences sector is heartbeat of Michigan innovation

click hereRead the rest

Retrosense Therapeutics: Tech innovators honored at Michigan Venture Capital Association awards dinner

click hereRead the rest

Retrosense Therapeutics: What Allergan Is Buying and Shedding to Gain a Better Position

click hereRead the rest

RetroSense to be honored at TechTown awards program for $60 million sale

click hereRead the rest

The RetroSense Story: A Life Science Journey to Success

click hereRead the rest

Retrosense Therapeutics: WSU research leads to algae treatment for blindness

click hereRead the rest

With small RetroSense deal, Allergan hoping for big win

click hereRead the rest

Allergan seizes visionary Optogenetic Therapy from US Startup Retrosense Therapeutics

click hereRead the rest

Allergan buys gene therapy company, RetroSense Therapeutics

click hereRead the rest

Allergan acquires RetroSense Therapeutics

click hereRead the rest

Allergan Acquires RetroSense Therapeutics

click hereRead the rest

Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline

click hereRead the rest

BRIEF-Allergan acquires gene therapy company Retrosense Therapeutics

click hereRead the rest

Allergan (AGN) Acquires RetroSense Therapeutics

click hereRead the rest

Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline

click hereRead the rest

Allergan snaps up gene therapy startup Retrosense Therapeutics to restore vision in rare disease patients

click hereRead the rest

RetroSense Therapeutics Secures Exclusive Worldwide Rights to ReaChR Optogene from the University of California San Diego

click hereRead the rest

RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics

click hereRead the rest

RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics

click hereRead the rest

RetroSense Therapeutics Completes Low Dose Cohort in Clinical Trial of Novel Gene Therapy Application of Optogenetics

click hereRead the rest

RetroSense Therapeutics has been named one of the nation’s 50 smartest companies by the MIT Technology Review

click hereRead the rest

RetroSense Therapeutics Tech magazine ranks Wayne State spinoff as 37th smartest company in world

click hereRead the rest

RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016

click hereRead the rest

RetroSense Therapeutics Selected as one of MIT Technology Review’s 50 Smartest Companies of 2016

click hereRead the rest

RetroSense Therapeutics Selected as a Red Herring Top 100 North America Winner

click hereRead the rest

Light-controlled genes and neurons poised for clinical trials

click hereRead the rest

RetroSense Therapeutics to Highlight Contributions to Gene Therapy Research in Upcoming Conferences

click hereRead the rest

Tech Coast Angels Invested Best Ever $16.37 Million in 2014

Southern California Angel Network Surpasses Previous Records for Both Investments and Activity

IRVINE, Calif. January 29, 2015 Tech Coast Angels (TCA) invested a total of $16,373,337 in 61 total deals in Calendar Year 2014. The angel network announced that 2014 was the most active year since the networks inception in 1997 for number of deals funded, and capital raised was also the largest ever.… Read the rest